XML 26 R13.htm IDEA: XBRL DOCUMENT v3.7.0.1
Note 7 - Accounts Payable and Accrued Expenses
12 Months Ended
Dec. 31, 2016
Notes to Financial Statements  
Accounts Payable and Accrued Liabilities Disclosure [Text Block]
Note
7.
Accounts Payable and Accrued Expenses
 
Accounts payable and accrued expenses included the following:
 
 
 
December 31,
 
 
December 31,
 
 
 
2015
 
 
2016
 
Accounts payable
  $
174,539
    $
22,231
 
Payroll tax liability
   
137,500
     
137,500
 
Officer bonus
   
     
80,000
 
Accrued interest
   
12,944
     
40,372
 
                 
Total Accounts Payable and Accrued Expenses
  $
324,983
    $
280,103
 
 
 
The payroll tax liability is our estimate of payroll taxes due on the past services of independent contractors. We are currently attempting to reduce the liability to approximately
$5,000
through the IRS Voluntary Classification Settlement Program.
 
On
September
27,
2016,
the board approved a
$
60,000
bonus for each of our Chief Executive and Chief Science Officers. As of
December
31,
2016,
$80,000
of this bonus remains to be paid. In
January
2017,
$
40,000
was paid to each of our Chief Executive and Chief Science Officer.
 
 
Issuance of Common Stock in exchange for payment of payables
 
Payment of Officer Salaries
 
During
2015
we issued
738,837
shares of our common stock at a range of
$0.35
-
$0.36
per share in lieu of
$309,975
of accrued and unpaid obligations to our officers. During
2016
we did not issue stock for service to our officers as their salaries were paid in cash.
 
 
Payment of Consultant Fees and Accrued Interest
 
During
2016,
we issued
2,342,264
shares of our common stock at a range of
$0.25
-
$0.83
per share in lieu of
$993,078
of accrued interest and accrued and unpaid obligations to consultants.
 
During
2015
we issued
631,643
shares of our common stock at a range of
$0.35
-
$0.36
per share in lieu of
$360,364
of accrued interest and accrued and unpaid obligations to consultants.
 
All of these offerings and sales were made in reliance on the exemption from registration contained in Section 
4(2)
of the Securities Exchange Act and/or Regulation D promulgated thereunder as not involving a public offering of securities.